ings at prostatectomy, adjuvant pelvic radiation may be provided postoperatively to reduce the risk of subsequent BCR [8] [9] [10] . Therefore, reliable prediction of BCR is important for providing the patient accurate prognostic information and making optimal treatment decisions.
To facilitate prediction of BCR, extensive efforts have been dedicated to development of clinical nomograms [11] [12] [13] . These models incorporate numerous clinical and pathologic parameters and complex interactions among such parameters to provide an individualized estimate of the likelihood of a given outcome [14] . In prediction of BCR, established postoperative nomograms have incorporated preoperative PSA level, Gleason score, tumor stage, tumor size, surgical margin status, and other features. These Recurrence After Radical Prostatectomy models have become widely adopted in clinical practice and decision making. Nonetheless, their performance remains suboptimal, and novel complementary biomarkers, such as those based on genetic profiling of tumors, are under active investigation [15] . Therefore, a means of improving the predictive accuracy of multivariate models for BCR would be of great clinical importance.
The apparent diffusion coefficient (ADC) value of prostate cancer, derived through DWI, has been found in numerous studies to have statistically significant correlation with the Gleason score of the tumor [16] [17] [18] and to be associated with tumor stage and progression in both active surveillance and radiation therapy cohorts. On this basis, ADC has come to be recognized as a key marker of the aggressiveness of prostate cancer. One past study [19] showed ADC to be predictive of BCR. In that study, however, no other clinical or pathologic features were observed to be significant independent predictors of BCR, and therefore no multivariate model could be constructed [19] . The overall accuracy of ADC alone as a single-factor predictor of BCR was similar to that of previously established clinical nomograms [14] . Since that study, more sophisticated ADC metrics have been found to have additive value as markers of tumor grade. Specifically, histogram-based whole-lesion ADC metrics have had stronger associations than mean ADC with Gleason score or primary Gleason grade [20, 21] . Such metrics have the potential to further improve on the role of ADC values in prediction of BCR. Our aim in this study was to investigate the additional value of whole-lesion histogram ADC metrics combined with standard pathologic features in prediction of BCR after radical prostatectomy for prostate cancer.
Materials and Methods Patients
This retrospective study was HIPAA compliant and approved by our institutional review board with a waiver of the requirement for written informed consent. A search of an institutional database to identify patients undergoing radical prostatectomy for prostate cancer who had undergone preoperative MRI at our institution between April 2011 and December 2013 yielded 432 patients. Prostate MRI was routinely performed for all patients awaiting radical prostatectomy at our institution during this time. Patients were then excluded for the following reasons: insufficient postoperative follow-up to establish a reference standard for BCR (n = 225); previous treatment of prostate cancer before MRI (n = 3); no tumor identified in prostatectomy specimen (stage pT0 tumor, n = 1) [22] ; MRI performed at 1.5 T (n = 8); and severe artifact on DW images (n = 2). These exclusions left a final included cohort of 193 patients (mean age, 61 ± 7 [SD] years; range, 43-80 years). The mean preoperative PSA level was 7.7 ± 8.8 ng/mL (range, 0.8-57.0 ng/mL).
MRI Technique
All patients underwent preoperative MRI with a whole-body 3-T system (Magnetom Trio, Skya, or Verio, Siemens Healthcare) and anterior and posterior phased-array coils. Examinations included axial turbo-spin echo T2-weighted imaging (TR/TE, 4000-4960/105; slice thickness, 3 mm; FOV, 180 × 180; matrix, 256 × 256; parallel imaging factor, 2; number of signals averaged, 3) and axial fat-suppressed single-shot echo-planar DWI (TR/TE, 4100/86; slice thickness, 3 mm; FOV, 200 × 200 mm; matrix, 100 × 220; parallel imaging factor, 2; number of signals averaged, 10; b values, 50 and 1000 s/mm 2 ) from which the ADC map was constructed on a voxel-wide basis with a standard monoexponential fit. Dynamic contrast-enhanced imaging was performed, but the images were not reviewed as part of this study.
Image Analysis
A radiologist with 2 years of experience in prostate imaging and blinded to clinical and pathologic information evaluated images using inhouse software (FireVoxel). The radiologist visually identified the lesion with the lowest ADC but did not consider any lesion with the characteristic appearance of benign prostatic hyperplasia on T2-weighted images. The radiologist then traced a 3D volume of interest (VOI) encompassing the entire lesion on the ADC map in all slices in which the lesion was visible (Fig. 1) . From the VOI, the histogram of ADC values within the lesion was constructed, which in turn was used to compute the mean, entropy, kurtosis, and skewness of ADC of the entire lesion. Kurtosis characterizes the peakedness of the distribution of ADC values within the VOI such that a sharper peak indicates larger kurtosis. (The kurtosis of the whole-lesion ADC histogram in this context is a distinct metric from the diffusional kurtosis obtained through nongaussian diffusion modeling [23] .) Skewness characterizes the distribution asymmetry, such that greater positive and negative skew indicate longer tails to the right and the left of the mean. Entropy characterizes the variation in the distribution such that greater entropy indicates greater unpredictability of ADC values. In addition, adjacent nonoverlapping sections of the histogram were defined by the 10th, 25th, and 50th percentiles of the distribution. The mean ADC values of these sections were computed and denoted as ADC 0-10 , ADC [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , and ADC . The volume of each VOI and whether the lesion was located predominantly within the peripheral zone or transition zone was also recorded.
Reference Standard
The electronic medical record was reviewed to identify PSA values obtained after radical prostatectomy. A PSA of 0.2 ng/mL or greater was considered to represent BCR [19] . For patients with BCR, the number of days from surgery to BCR was recorded. For patients without BCR, an undetectable PSA at least 1 year after the date of surgery was required for the patient to be classified as having negative findings for BCR and to be included in the analysis. For such patients, the number of days from surgery to the most recently available undetectable PSA result was recorded. Patients with either no postoperative PSA data or less than 1 year of undetectable PSA results were considered unable to be classified as having positive or negative results for BCR and were excluded from the study.
Additional information extracted from the electronic medical record for each patient included the following histopathologic features determined from assessment of the prostatectomy specimen: primary Gleason grade (classified as 3 vs > 3), overall Gleason score (classified as 6 vs > 6), peri- 
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neural invasion, extraprostatic extension, seminal vesicle invasion, metastatic lymphadenopathy, and positive surgical margin. Also recorded for each patient was whether adjuvant radiation therapy was administered in the immediately postoperative period. Adjuvant radiation therapy was administered to select patients deemed at high risk of BCR on the basis of histopathologic findings, even though by definition they had an undetectable PSA level at the time of adjuvant therapy.
Statistical Analysis
Patients with and without BCR were compared by Fisher exact test for binary factors and MannWhitney tests for continuous factors. For binary factors with a significant association, the sensitivity and specificity for BCR were computed. For continuous factors with a significant association with BCR, the AUC from ROC curve analysis was computed along with the sensitivity and specificity at the value that maximized the Youden index subject to a constraint of a specificity of at least 70% in view of the large imbalance of patients with and without BCR. Stepwise variable selection in the context of logistic regression was used to identify sets of independent predictors of BCR from among all binary and continuous factors serving as significant predictors of BCR during the initial univariable assessments. According to the model obtained from the multivariable assessment, the AUC and the sensitivity and specificity corresponding with the model criterion maximizing the Youden index subject to a constraint of a specificity of at least 70% were computed. ROC analysis was used to compare the performance of the multivariable model with that of the individual factors in the model and with that of the model exclusive of diffusion-based metrics. Cox proportional hazards regression was used to assess the utility of the multivariable model for predicting the time to BCR, summarized by use of the Harrell concordance index (c-index). All statistical tests were conducted at the two-sided 5% significance level with SAS software (version 9.3, SAS Institute).
Results

Clinical and Pathologic Data
At prostatectomy, the distribution of prima- BCR occurred in 16.6% (32/193) of patients. In patients with BCR, the mean time from surgery to BCR was 305 ± 254 days (median, 893 days). In patients without BCR, the mean duration of a negative PSA result in postoperative follow-up was 618 ± 176 days (median, 594 days). Tables 1 and 2 show the results of the univariable assessments for prediction of BCR.
Univariable Assessments
Almost all study parameters included in the study had significant associations with BCR. Patients with BCR were significantly (p ≤ 0.019) more likely to have a primary Gleason pattern > 3, a Gleason score > 6, extraprostatic extension, seminal vesicle invasion, perineural invasion, positive surgical margins, and metastatic lymphadenopathy. The sensitivity of these factors for prediction of BCR ranged from 15.6% (metastatic lymphadenopathy) to 96.9% (extraprostatic extension), and specificity ranged from 36.0% (perineural invasion) to 99.4% (metastatic lymphadenopathy). In addition, patients with BCR had a significantly higher preoperative PSA level, MRI tumor volume, and ADC entropy, as well as significantly lower mean ADC, ADC 0-10 , ADC [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , and ADC [25] [26] [27] [28] [29] [30] (p ≤ 0.003). The AUC for these 
Multivariable Assessment
Multivariable assessment identified primary Gleason grade, extraprostatic extension, ADC 0-10 , and entropy ADC as significant independent predictors of BCR ( Table  3 ). The p values for these factors, each adjusted for the other three parameters, ranged from 0.002 to 0.037. Together these factors had an AUC for prediction of BCR of 0.94 with sensitivity of 93.8% and specificity of 87.0%. The AUC of this model was significantly greater than the AUC of any of the individual factors within the model alone (p < 0.001, all comparisons) and significantly greater than the AUC of the model when the two ADC metrics (AUC = 0.89, p = 0.001) were excluded. The c-index for prediction of time to BCR for the multivariable model was 0.91. Figure 4 shows the ROC curves for the multivariable model, the multivariable model without the ADC metrics, and of the individual ADC metrics.
Discussion
In this study, we developed a multivariable model for prediction of BCR of prostate cancer that combines the established clinical parameters of Gleason grade and extraprostatic extension with whole-lesion ADC metrics. Although it must be validated in external cohorts, the model had high performance within this initial cohort for prediction of both BCR (AUC, 0.94) and time until BCR (c-index, 0.91). These values compare favorably with those reported for other established models of prediction of BCR based on clinical and pathologic postprostatectomy data. For instance, studies of standard postprostatectomy algorithms have shown a c-index ranging from 0.76 to 0.82 [11, 13, 24, 25] , indicating the limitations of current models. Another study integrating gene expression profiling along with standard parameters [15] showed a c-index of 0.89, although such techniques are not currently widely applied. The strong performance that we report for the model integrating standard parameters and ADC-based metrics supports a potential compelling clinical role for this approach in terms of guiding postoperative prognosis and decisions regarding adjuvant therapy.
Among the ADC metrics, ADC 0-10 , but not mean ADC, was selected for inclusion in the multivariable model for prediction of BCR. In a similar fashion, Donati et al. [20] observed the 10th percentile ADC to have a significantly higher AUC than mean ADC for prediction of Gleason score. Peng et al. [26] also observed the 10th percentile ADC to have slightly higher sensitivity and specificity than mean ADC for differentiation of benign and malignant prostate tissue. In our study, the higher performance of ADC 0-10 in identifying aggressive prostate cancer may reflect the histologic heterogeneity of prostate cancer, comprising proportions of benign gland and malignant epithelium [27, 28] . In particular, among the various metrics, the mean value may be more heavily affected by intermixed benign tissue, whereas the ADC 0-10 may more strongly reflect focal regions of aggressive elements within the overall tumor volume [20] . In addition to ADC 0-10 , entropy ADC was a significant independent predictor of ADC. Its role as an independent predictor can be attributed to its distinct nature in comparison with the other ADC metrics identified at univariable evaluation. Entropy reflects tissue heterogeneity, being influenced by variability and predictability of ADC values within the histogram [21] . A past study [21] showed that ADC entropy has a stronger association with the percentage Gleason 4 component within prostate tumors than mean ADC does. Given its complex derivation and reflection of overall lesion texture, lesion entropy cannot be approximated on the basis of qualitative image assessment or a focal ROI evaluation with a standard clinical PACS. Rather, this parameter generally entails whole-lesion analysis with dedicated image analysis software. As data continue to emerge in support of the prognostic value of whole-lesion histogram-based assessment, such methods may become more routine in clinical practice.
Past studies have also explored associations between MRI findings and BCR. Park et al. [19] observed mean ADC from a single-slice ROI to have an AUC of 0.755 for prediction of BCR, although no model combining mean ADC with clinical or pathologic parameters could be identified. More recently, Park et al. [29] described a multivariable model combining standard clinical factors and the mere qualitative presence of visible tumor on MR images; however, the overall accuracy, sensitivity, and specificity of the multivariable model constructed in that study were not reported [29] . Other, more remote studies based on subjective MRI assessments [30, 31] did not show significant improvements in prognostic accuracy through MRI findings. On this basis, the more advanced quantitative analysis used in our study appears to be an important component of optimizing the potential utility of MRI in prostate cancer risk assessment.
A number of limitations of our study warrant mention. First, this was a retrospective study, with a small number of patients with positive results for BCR. In addition, the Recurrence After Radical Prostatectomy minimum follow-up interval for considering patients not to have BCR was 12 months. Although this matches the minimum follow-up interval applied in a previous study of prediction of BCR [19] , it is expected that a fraction of these patients would have had BCR with longer surveillance. Furthermore, we included patients who had undergone adjuvant radiation therapy. Current national consensus guidelines advise offering such treatment to patients with high-risk pathologic features of BCR [10] , so exclusion of such patients would have caused our model not to apply to a subset of patients at highest risk of the outcome of interest. Nonetheless, the rate of adjuvant radiation therapy in our cohort was low. This may relate to the frequent use at our institution of early salvage therapy [9, 32] . Moreover, although preoperative radiation therapy has been used in nomograms for prediction of BCR [33] , we excluded patients with preoperative treatment because of the potential effect of such therapy on ADC values. Another limitation was the exclusion of approximately one half of patients undergoing prostatectomy at our institution during the study interval owing to insufficient PSA follow-up, potentially biasing the results. In addition, interreader reproducibility of the whole-lesion ADC metrics was not assessed. Finally, our observations require validation in separate independent cohorts to establish the generalizability of the model.
Conclusion
We developed a multivariable model combining primary Gleason grade, extraprostatic extension, and both ADC 0-10 and entropy ADC from whole-lesion tumor assessment in prediction of BCR of prostate cancer. Together these factors had excellent performance within this initial cohort, achieving an AUC of 0.94. The selection of these two ADC metrics, but not of standard mean ADC, for inclusion in the model indicates the value of whole-lesion histogram analysis for optimizing characterization of tumor aggressiveness. This multivariable model may have clinical application in postoperative assessments of prognosis and treatment decisions. Future validation in independent cohorts remains warranted.
